Platelet ‘decoys’ outsmart both clots and cancer
A team of researchers at the Wyss Institute at Harvard University and several collaborating institutions has created a drug-free, reversible antiplatelet therapy that uses deactivated “decoy” platelets to reduce the risk of blood clots and potentially prevent cancer metastasis.
Lindsay Brownell
• harvard
Feb. 13, 2019 • ~8 min
Feb. 13, 2019 • ~8 min
/
1